Scientists design chemicals to fight flu
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SCIENTISTS say they have made a breakthrough in developing a drug to prevent and treat flu, with the design of two chemicals which appear to stop the virus multiplying in animal cells.
The flu virus has so far defeated the best efforts of the immune system and medical science in preventing or fighting the infection.
The virus manages to stay one step ahead through its ability to regularly modify two key proteins on its surface coat. Antibodies produced against one particular strain are useless against another, which has altered surface proteins.
Using computer-aided biochemical techniques, scientists at Monash University, Victoria, Australia, have designed molecules specifically to target one of these proteins, known as sialidase.
Sialidase is thought to help the virus penetrate the lining of the respiratory tract, and plays a role in the release of new viruses from infected cells. When tested in laboratory cell cultures and in a range of animals, the molecules had a potent anti-viral effect, according to the journal Nature.
The researchers, lead by Mark Von Itzstein, said that the two compounds 'may be useful leads for the development of novel anti-influenza drugs'. In an accompanying article, Garry Taylor, from the University of Bath, said that the results would 'excite and encourage' those involved in drug design.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments